Verified earnings results

Regeneron Pharmaceuticals Q3 2026 Earnings Results

Direct answer

Regeneron Pharmaceuticals reported Q3 2026 results on October 30, 2026.

Revenue was 5,115,800,000. EPS beat the estimate by 21.18%.
The result is verified against Verified earnings source.
Verified earnings source

Get free Regeneron Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
October 30, 2026
Reported timing
Before the US market opens
EPS estimate
16.5625
Reported EPS
20.07
Revenue
5,115,800,000
EPS surprise
EPS beat the estimate by 21.18%.

Read the frequently asked questions.

When did Regeneron Pharmaceuticals report Q3 2026 earnings?

Regeneron Pharmaceuticals reported on October 30, 2026. The reported timing was before the us market opens.

What is the available EPS estimate for Regeneron Pharmaceuticals?

The verified record provides an EPS estimate of 16.5625.

Has Regeneron Pharmaceuticals reported the Q3 2026 result?

Revenue was 5,115,800,000. EPS beat the estimate by 21.18%.

Which source supports this Regeneron Pharmaceuticals earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.